FNB
GSK icon

Farmers National Bank’s GSK GSK Stock Holding History

Farmers National Bank’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$366K Sell
7,324
-1,310
-15% -$65.7K 0.19% 96
2019
Q1 		$451K Buy
+8,634
New +$431K 0.25% 83
2018
Q2 		$589K Sell
11,684
-262
-2% -$13.2K 0.36% 69
2018
Q1 		$583K Sell
11,946
-660
-5% -$30.7K 0.36% 70
2017
Q4 		$559K Sell
12,606
-1,411
-10% -$65.2K 0.32% 77
2017
Q3 		$711K Sell
14,017
-740
-5% -$37.5K 0.43% 59
2017
Q2 		$795K Buy
14,757
+2,817
+24% +$150K 0.47% 53
2017
Q1 		$644K Sell
11,940
-2,767
-19% -$140K 0.38% 63
2016
Q4 		$708K Buy
14,707
+2,767
+23% +$137K 0.41% 60
2016
Q3 		$644 Sell
11,940
-10,127
-46% -$555K 0.19% 65
2016
Q2 		$1.2M Sell
22,067
-1,644
-7% -$86.6K 0.71% 40
2016
Q1 		$1.2M Buy
23,711
+1,757
+8% +$87.5K 0.79% 36
2015
Q4 		$1.11M Buy
21,954
+833
+4% +$42.5K 0.8% 38
2015
Q3 		$1.01M Buy
21,121
+2,193
+12% +$114K 0.8% 33
2015
Q2 		$985K Sell
18,928
-888
-4% -$50K 0.75% 35
2015
Q1 		$1.14M Sell
19,816
-396
-2% -$22.7K 0.87% 36
2014
Q4 		$1.08M Buy
+20,212
New +$1.13M 0.89% 33

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Farmers National Bank's GSK Position: Q2 2019 in Review

Farmers National Bank reduced its GSK (GSK) stake by 15% in Q2 2019, selling an estimated $65.7K and leaving 7,324 shares worth $366K. The position accounts for 0.19% of the portfolio, ranked #96.

Farmers National Bank first reported a position in GSK in Q4 2014 and has held it in 17 quarters since. The position peaked at $1.2M in Q1 2016. 804 funds tracked by Wall St. Rank hold GSK as of Q2 2019.

  • Farmers National Bank held 7,324 shares of GSK worth $366K as of Q2 2019.
  • Farmers National Bank sold 1,310 GSK shares in Q2 2019, an estimated $65.7K.
  • GSK made up 0.19% of Farmers National Bank's portfolio in Q2 2019, its #96 holding.
  • Farmers National Bank first reported a position in GSK in Q4 2014 and has held it in 17 quarters since.
  • Farmers National Bank's GSK position peaked at $1.2M in Q1 2016.
  • 804 funds tracked by Wall St. Rank held GSK as of Q2 2019.

Based on Farmers National Bank's 13F filing for Q2 2019, filed 22 Aug 2019.